FIRST MANHATTAN CO. LLC. Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$37.9B

Holdings

714

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (714 positions)

#StockSharesValue% PortfolioType
701
OGNORGANON & CO
10,438$111.5M0.29%
702
TSHATAYSHA GENE THERAPIES INC
28,500$93.2M0.25%
703
CLSDQCLEARSIDE BIOMEDICAL INC
22,846$90.7M0.24%
704
OPKOPKO HEALTH INC
51,750$80.2M0.21%
705
VLNVALENS SEMICONDUCTOR LTD
43,458$77.8M0.21%
706
PTENPATTERSON-UTI ENERGY INC
14,041$72.7M0.19%
707
KLTRKALTURA INC
50,000$72.0M0.19%
708
I9DNARBUTUS BIOPHARMA CORP
14,000$63.6M0.17%
709
ZVIAZEVIA PBC
22,000$59.8M0.16%
710
DCFEURMOGO INC
26,400$48.8M0.13%
711
CALCCALCIMEDICA INC
13,226$40.7M0.11%
712
OVIDOVID THERAPEUTICS INC
26,000$33.8M0.09%
713
GROVGROVE COLLABORATIVE HOLD INC
11,662$17.5M0.05%
714
PDSBPDS BIOTECHNOLOGY CORP
15,000$15.2M0.04%
PreviousPage 8 of 8